Celsius Holdings, Inc. faces a proposed federal securities class action alleging that it made materially false or misleading statements and omissions concerning cardiac risks associated with Alani Nu products. Bronstein, Gewirtz & Grossman, LLC said the lawsuit covers investors who purchased or acquired Celsius securities between February 21, 2025, and June 3, 2026. The complaint alleges that Alani Nu products did not adequately disclose cardiac risks and that Celsius marketed the beverages to consumers under 18, who were particularly susceptible to the products' known health risks. It further claims consumers faced a material risk of potentially fatal adverse health events and that disclosure of those risks was likely to significantly damage Celsius's business and reputation. Investors seeking appointment as lead plaintiff must apply by November 3, 2026. Investors do not need to serve as lead plaintiff to participate in any potential recovery.